Verywell Health on MSN
More Price Cuts Are Coming for Diabetes Drugs. Here's What to Expect in 2026
Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...
News Medical on MSN
GLP-1 drugs calm inflammation beyond diabetes and weight loss
This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...
News-Medical.Net on MSN
Do GLP-1 drugs cause cancer? New review says no, may even protect
A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...
A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...
Research from the University of Nebraska has resulted in clear advice: Don't nuke plastics. Our "just pop it in the microwave" mentality is unleashing hordes of tiny plastic particles — more than 2 ...
Health and Me on MSN
Taking Ozempic, Wegovy, or Mounjaro? Experts Warn Of Rare But Severe Reaction
Health officials have issued a warning for Ozempic, Wegovy, Rybelsus, and Mounjaro users after reports of severe reactions linked to GLP-1 drugs. Here’s what the alert means and how to stay safe. Keep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results